G.P Seed-VC|Investin... • 8m
Niket Raj Dwivedi Your Platform is growing & this is the Sign.. Even though this is a bad sign but good to know that people are aware & using. So, Make it a better place by restricting some people.. Or else, Target Audience starts to leave. Thanks in Advance 🤝
•
Helixworks Technologies • 6m
From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power
See MoreDownload the medial app to read full posts, comements and news.